Evidence map›Paper›PMID 1741377›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1992

Coexpression of mu and gamma 1 heavy chains can occur by a discontinuous transcription mechanism from the same unrearranged chromosome.

M Nolan-Willard, M T Berton, P Tucker

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. DNA rearrangement can account for in vitro switching to IgG1.The Journal of experimental medicine · 1993
    Article
  5. Article
  6. Regulation of IgE synthesis: from the membrane to the genes.Springer seminars in immunopathology · 1993
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

M Nolan-WillardUniversity of Texas Southwestern Medical Center, Department of Microbiology, Dallas 75235.
M T Berton
P Tucker

Funding

MAR MEDIATED GENETIC SWITCH FOR IGH ENHANCER CONTROLR01CA031534 · NCI · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI TUCKER, HALEY O · 1985 to 2012
$2.9M
NCI NIH HHS CA31534
6 · The paper itself

Abstract

We previously documented that a single BCL1 leukemia cell can produce mu and gamma 1 immunoglobulin heavy chains with identical variable segments in an allelically excluded fashion without heavy chain constant region gene rearrangement. To understand the mechanism of dual mu/gamma 1 synthesis in BCL1 subclones, we have analyzed mature and pre-RNA at the nascent and steady-state levels. We find mu and gamma 1 sequences linked in pre-RNA. However, the primary mu and gamma 1 transcription units are about the same length (approximately 15 kilobases). Initiation of gamma 1 pre-RNA occurs upstream of C gamma 1 at sites identical to those seen in lipopolysaccharide/interleukin-4-induced normal B cells. We propose that dual mu/gamma 1 RNA synthesis occurs by a discontinuous transcription mechanism involving either trans-splicing or ligation of mu pre-RNA initiated 5' of the variable-diversity-joining region to gamma 1 pre-RNA initiated 5' of C gamma 1.

Indexed as

Genes, ImmunoglobulinTranscription, GeneticAnimalsCell NucleusDNA-Directed RNA PolymerasesGene Expression RegulationGene Rearrangement, B-Lymphocyte, Heavy ChainImmunoglobulin gamma-ChainsImmunoglobulin IsotypesImmunoglobulin mu-ChainsLeukemia, B-CellMiceNucleic Acid PrecursorsRestriction MappingRNA, MessengerTumor Cells, CulturedDNA-Directed RNA PolymerasesImmunoglobulin gamma-ChainsImmunoglobulin IsotypesImmunoglobulin mu-ChainsNucleic Acid PrecursorsRNA, Messenger

Identifiers

PMID1741377
PMCPMC48423

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.